Cargando…
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells
Typically, anticancer CD8(pos) T cells occur at low frequencies and become increasingly impaired in the tumor micro environment. In contrast, antiviral CD8(pos) T cells display a much higher polyclonality, frequency, and functionality. In particular, cytomegalovirus (CMV) infection induces high numb...
Autores principales: | Britsch, Isabel, van Wijngaarden, Anne P., Ke, Xiurong, Hendriks, Mark. A.J.M., Samplonius, Douwe F., Ploeg, Emily M., Helfrich, Wijnand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173793/ https://www.ncbi.nlm.nih.gov/pubmed/37180637 http://dx.doi.org/10.1080/2162402X.2023.2207868 |
Ejemplares similares
-
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
por: Hendriks, Mark A.J.M., et al.
Publicado: (2021) -
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
por: Ploeg, Emily Maria, et al.
Publicado: (2023) -
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023) -
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
por: Hendriks, Mark A. J. M., et al.
Publicado: (2020) -
Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy
por: Britsch, Isabel, et al.
Publicado: (2023)